Pathologist Sues PubPeer Users

A professor who was terminated from a new job before he’d even started is suing users of the post-publication peer review forum for allegedly making defamatory statements.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, BRIAN TURNERWayne State University pathologist Fazlul Sarkar is suing certain users of the post-publication peer review forum PubPeer, demanding that the website’s moderators release identifying information pertaining to anonymous comments that—according to his lawyer, Nicholas Roumel—allegedly contain defamatory statements about Sarkar.

When The Scientist first reported on a perceived legal threat to the website in August, Sarkar’s identity was not yet released, nor were his chief complaints. A month later it was revealed, through Roumel and a post at PubPeer, that anonymous comments posted to the website allegedly cost Sarkar a job. According to Retraction Watch, officials at the University of Mississippi rescinded an offer Sarkar had already accepted based on anonymous comments posted to PubPeer questioning some of the pathologist’s publications.

In a complaint filed with Michigan’s Wayne County Circuit Court (posted by Retraction Watch), Roumel noted that Ole Miss’s offer of tenured professorship to Sarkar included, among other things, a $750,000 start-up package, an annual salary of $350,000, relocation expenses up to $15,000, lab ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies